Luke is a Portfolio Planning Systems Analyst at Biogen while pursuing his MS in biotechnology operations & enterprise at Northeastern University (expected 2026). After an outstanding co-op performance, he was offered a six-month co-op extension to drive key cross-functional initiatives. 

Luke specializes in timeline optimization and strategic portfolio management, earning recognition as both an asset program manager and a project manager for leadership teams across Biogen’s U.S., U.K., and Swiss operations. He thrives on building strong relationships and aligning diverse stakeholders to improve drug development through innovative, team-driven portfolio strategies.